The biomarker to companion diagnostic continuum a road map for the delivery of precision medicine

The biomarker to companion diagnostic continuum a road map for the delivery of precision medicine

Webinar: Companion Diagnostics and Clinical Development in Oncology: A Statistical PerspectiveПодробнее

Webinar: Companion Diagnostics and Clinical Development in Oncology: A Statistical Perspective

Genomenon Pharma Webinar | Genomic Biomarker Selection for Companion Diagnostic DevelopmentПодробнее

Genomenon Pharma Webinar | Genomic Biomarker Selection for Companion Diagnostic Development

Keynote Presentation: Predictive Biomarkers to Diagnostic Tests Scientific..Подробнее

Keynote Presentation: Predictive Biomarkers to Diagnostic Tests Scientific..

Panel Discussion: Co-development of Drugs and Companion DiagnosticsПодробнее

Panel Discussion: Co-development of Drugs and Companion Diagnostics

Dr. Bunn Discusses Companion Diagnostic Tests in Lung CancerПодробнее

Dr. Bunn Discusses Companion Diagnostic Tests in Lung Cancer

Sengenics KREX technology for biomarker discovery, patient stratification and companion diagnosticsПодробнее

Sengenics KREX technology for biomarker discovery, patient stratification and companion diagnostics

The Companion Diagnostics (CDx) Market in ContextПодробнее

The Companion Diagnostics (CDx) Market in Context

Biomarker Based Companion Diagnostics Are Enabling Precision OncologyПодробнее

Biomarker Based Companion Diagnostics Are Enabling Precision Oncology

The Biomarker Qualification Process: A Roadmap for RequestorsПодробнее

The Biomarker Qualification Process: A Roadmap for Requestors

How is biomarker testing carried out?Подробнее

How is biomarker testing carried out?

What’s Next in Precision Medicine? Small Molecule Biomarkers to Personalize Diagnostics & TherapiesПодробнее

What’s Next in Precision Medicine? Small Molecule Biomarkers to Personalize Diagnostics & Therapies

Planning for Co-development of Companion DiagnosticsПодробнее

Planning for Co-development of Companion Diagnostics

Key Considerations for Co-developing Therapeutics and Companion DiagnosticsПодробнее

Key Considerations for Co-developing Therapeutics and Companion Diagnostics

Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020 2026Подробнее

Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2020 2026

Companion Diagnostic and Biomarker Assay Development for Interrogation of Liquid and Solid TumorПодробнее

Companion Diagnostic and Biomarker Assay Development for Interrogation of Liquid and Solid Tumor

Enabling Translation of Biomarker Research to Clinical PracticeПодробнее

Enabling Translation of Biomarker Research to Clinical Practice

A Precision Medicine Roadmap for Rx and CDx Co-development and Regulatory Approval in JapanПодробнее

A Precision Medicine Roadmap for Rx and CDx Co-development and Regulatory Approval in Japan

Identification of Novel Protein Biomarkers in the Era of Precision Medicine OncologyПодробнее

Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology